Viewing Study NCT00960492


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2026-01-04 @ 3:53 PM
Study NCT ID: NCT00960492
Status: COMPLETED
Last Update Posted: 2014-09-22
First Post: 2009-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
Sponsor: Exelixis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module